Form 4: UnitedHealth Group Executive Cianfrocco Reports Stock and Options Transactions

Heather Cianfrocco, Chief Executive Officer of Optum, reports acquisition of common stock and non-qualified stock options in UnitedHealth Group.

Summary

• On June 3, 2024, Heather Cianfrocco, Chief Executive Officer of Optum (a subsidiary of UnitedHealth Group), reported transactions involving UnitedHealth Group's securities.
• Cianfrocco acquired 252 shares of common stock at $0, and these shares are restricted stock units vesting at a rate of 25% annually from June 3, 2025, through June 3, 2028.
• Additionally, Cianfrocco acquired 937 non-qualified stock options with an exercise price of $497.44, vesting at a rate of 25% annually from June 3, 2025, through June 3, 2028.
• Following these transactions, Cianfrocco directly owns 17,315.885 shares of common stock and 937 non-qualified stock options.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices and insider confidence. There are no indications of negative events or concerns.

Positives

• The acquisition of stock and options by a key executive signals confidence in the company's future performance.

Future Outlook

The vesting schedule of the restricted stock units and non-qualified stock options suggests a long-term commitment by the executive to the company's success.

Industry Context

Executive stock ownership is a common practice in publicly traded companies like UnitedHealth Group to align management's interests with those of shareholders. These transactions are routinely monitored and reported to the SEC.

Comparison to Industry Standards

• Executive compensation packages, including stock options and restricted stock units, are standard practice among large healthcare companies such as CVS Health, Anthem (Elevance Health), and Cigna.
• The vesting schedules and exercise prices are typically benchmarked against industry peers to attract and retain top talent.
• The amount of equity granted to executives is often tied to company performance and strategic goals, aligning their interests with shareholder value creation.

Stakeholder Impact

• The reported transactions could have a minor positive impact on shareholder sentiment, reflecting confidence from a key executive.

Key Dates